• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B族链球菌Ⅲ型多糖抗体的定量测定

Quantitative determination of antibodies to type III group B streptococcal polysaccharide.

作者信息

Guttormsen H K, Baker C J, Edwards M S, Paoletti L C, Kasper D L

机构信息

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

J Infect Dis. 1996 Jan;173(1):142-50. doi: 10.1093/infdis/173.1.142.

DOI:10.1093/infdis/173.1.142
PMID:8537651
Abstract

The susceptibility of neonates to invasive infection with type III group B streptococci (GBS) in a radioactive antigen-binding assay (RABA) has been correlated with low maternal serum levels of capsular polysaccharide-specific antibodies. An ELISA was developed using capsular polysaccharide covalently coupled to human serum albumin. In sera from 35 healthy women, the range of IgG antibodies to GBS III polysaccharide was 0.05-33.0 micrograms/mL, and specific IgA antibodies were 0.08-1.1 micrograms/mL; however, no GBS III capsular polysaccharide-specific antibodies of the IgM isotype were detected by the ELISA. The levels of naturally acquired and vaccine-induced antibodies obtained with this ELISA correlated well with the results of the RABA (Spearman's rank correlation coefficient, .92). The ELISA has two major advantages over the RABA: It measures specific isotypes and subclasses of antibodies, and it can detect type III polysaccharide-specific antibodies at lower concentrations.

摘要

在放射性抗原结合试验(RABA)中,新生儿对B族链球菌III型(GBS)侵袭性感染的易感性与母体血清中荚膜多糖特异性抗体水平较低相关。利用与人类血清白蛋白共价偶联的荚膜多糖开发了一种酶联免疫吸附测定(ELISA)。在35名健康女性的血清中,GBS III多糖的IgG抗体范围为0.05 - 33.0微克/毫升,特异性IgA抗体为0.08 - 1.1微克/毫升;然而,ELISA未检测到IgM同种型的GBS III荚膜多糖特异性抗体。用该ELISA获得的自然获得性抗体和疫苗诱导抗体水平与RABA结果高度相关(斯皮尔曼等级相关系数为0.92)。与RABA相比,ELISA有两个主要优点:它可测量抗体的特异性同种型和亚类,并且能够检测更低浓度的III型多糖特异性抗体。

相似文献

1
Quantitative determination of antibodies to type III group B streptococcal polysaccharide.B族链球菌Ⅲ型多糖抗体的定量测定
J Infect Dis. 1996 Jan;173(1):142-50. doi: 10.1093/infdis/173.1.142.
2
Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.母体血清、脐带血血清及母乳中抗B族链球菌III型多糖抗体和抗破伤风类毒素抗体的同种型组成。
Eur J Pediatr. 1992 Feb;151(2):98-102. doi: 10.1007/BF01958951.
3
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.对III型B族链球菌多糖-破伤风类毒素结合疫苗的免疫反应。
J Clin Invest. 1996 Nov 15;98(10):2308-14. doi: 10.1172/JCI119042.
4
Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.通过用四价B族链球菌多糖-破伤风类毒素结合疫苗进行母体免疫,对新生小鼠进行多种B族链球菌(GBS)血清型感染的保护。
Infect Immun. 1994 Aug;62(8):3236-43. doi: 10.1128/iai.62.8.3236-3243.1994.
5
Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.天然获得性及疫苗诱导产生的抗Ⅲ型B族链球菌荚膜多糖抗体的类特异性:采用放射免疫沉淀试验进行测定
Infect Immun. 1984 May;44(2):257-61. doi: 10.1128/iai.44.2.257-261.1984.
6
Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.人血清中B族链球菌III型多糖特异性抗体浓度的测定取决于抗原。
Infect Immun. 1998 Dec;66(12):5848-53. doi: 10.1128/IAI.66.12.5848-5853.1998.
7
Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.V 型 B 族链球菌多糖-破伤风类毒素结合疫苗在动物体内的免疫原性和保护活性
J Infect Dis. 1995 Apr;171(4):879-84. doi: 10.1093/infdis/171.4.879.
8
Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.用III型B族链球菌荚膜多糖-霍乱毒素B亚单位结合疫苗进行黏膜免疫后小鼠的全身和黏膜免疫反应
Infect Immun. 2000 Oct;68(10):5749-55. doi: 10.1128/IAI.68.10.5749-5755.2000.
9
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.健康女性对两种不同的B族链球菌V型荚膜多糖-蛋白结合疫苗的免疫反应。
J Infect Dis. 2004 Mar 15;189(6):1103-12. doi: 10.1086/382193. Epub 2004 Mar 1.
10
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.III型B族链球菌多糖诱导产生的抗体与14型肺炎链球菌发生交叉反应。
Infect Immun. 2002 Apr;70(4):1724-38. doi: 10.1128/IAI.70.4.1724-1738.2002.

引用本文的文献

1
Development of A Standardized Opsonophagocytosis Killing Assay for Group B and Assessment in an Interlaboratory Study.B组标准化调理吞噬杀伤试验的开发及实验室间研究评估
Vaccines (Basel). 2023 Nov 9;11(11):1703. doi: 10.3390/vaccines11111703.
2
Calibration of a serum reference standard for Group B streptococcal polysaccharide conjugate vaccine development using surface plasmon resonance.使用表面等离子体共振对B族链球菌多糖结合疫苗开发的血清参考标准品进行校准。
NPJ Vaccines. 2023 May 19;8(1):71. doi: 10.1038/s41541-023-00667-1.
3
Novel Multiplex Immunoassays for Quantification of IgG against Group B Capsular Polysaccharides in Human Sera.
新型多重免疫分析检测人血清中针对 B 群荚膜多糖的 IgG 抗体。
mSphere. 2019 Aug 7;4(4):e00273-19. doi: 10.1128/mSphere.00273-19.
4
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.III 型 B 群链球菌(GBS)荚膜多糖-破伤风类毒素(GBS III-TT)疫苗预防 III 型 GBS 阴道定植的 2 期、随机、对照试验。
Clin Infect Dis. 2019 May 30;68(12):2079-2086. doi: 10.1093/cid/ciy838.
5
Progress toward a group B streptococcal vaccine.B族链球菌疫苗的进展。
Hum Vaccin Immunother. 2018;14(11):2669-2681. doi: 10.1080/21645515.2018.1493326. Epub 2018 Jul 16.
6
Status of group B streptococcal vaccine development.B族链球菌疫苗的研发现状。
Clin Exp Vaccine Res. 2018 Jan;7(1):76-81. doi: 10.7774/cevr.2018.7.1.76. Epub 2018 Jan 29.
7
Immune Responses to Invasive Group B Streptococcal Disease in Adults.成人侵袭性B族链球菌病的免疫反应
Emerg Infect Dis. 2016 Nov;22(11):1877-1883. doi: 10.3201/eid2211.160914.
8
The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways.B族链球菌分泌蛋白CIP与C4相互作用,通过凝集素和经典补体途径阻止C3b沉积。
J Immunol. 2016 Jan 1;196(1):385-94. doi: 10.4049/jimmunol.1501954. Epub 2015 Nov 25.
9
Isolation of highly active monoclonal antibodies against multiresistant gram-positive bacteria.针对多重耐药革兰氏阳性菌的高活性单克隆抗体的分离
PLoS One. 2015 Feb 23;10(2):e0118405. doi: 10.1371/journal.pone.0118405. eCollection 2015.
10
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.分娩时的母体抗体可保护新生儿免受早发型 B 组链球菌病的侵害。
J Infect Dis. 2014 Mar 1;209(5):781-8. doi: 10.1093/infdis/jit549. Epub 2013 Oct 16.